Profiel
Jerry Cacia worked as the Global Head of Pharmaceutical Technical Development at Genentech, Inc. from 1988 to 2016.
He then served as the Head of Biologics & Drug Product Manufacturing at F.
Hoffmann-La Roche Ltd. from 2016 to 2021.
Currently, he is the Chief Technical Officer at Graphite Bio, Inc. since 2021.
Mr. Cacia completed his undergraduate degree at the University of California, Santa Cruz.
Eerdere bekende functies van Jerry Cacia
| Bedrijven | Functie | Einde |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2023 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-02-2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jerry Cacia
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
















